NEXIEN BIOPHARMA, INC. Quarterly Entity Common Stock, Shares Outstanding from Q4 2014 to Q4 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Nexien Biopharma, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2014 to Q4 2024.
  • Nexien Biopharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 18, 2024 was 70.8M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 70.8M Nov 18, 2024 10-Q 2024-11-18
Q3 2024 70.8M +6M +9.26% Oct 22, 2024 10-K 2024-10-22
Q1 2024 67.5M +3.95M +6.22% Feb 20, 2024 10-Q 2024-02-20
Q3 2023 64.8M +3.5M +5.71% Sep 25, 2023 10-K 2023-09-28
Q1 2023 63.5M +3M +4.96% May 15, 2023 10-Q 2023-05-17
Q4 2022 62.8M +2.75M +4.58% Feb 6, 2023 10-Q 2023-02-08
Q3 2022 61.3M +5.5M +9.86% Sep 26, 2022 10-K 2022-09-28
Q1 2022 60.5M +5M +9.01% May 12, 2022 10-Q 2022-05-12
Q4 2021 60M +4.09M +7.31% Feb 4, 2022 10-Q 2022-02-08
Q3 2021 55.8M -9K -0.02% Oct 12, 2021 10-K 2021-10-12
Q1 2021 55.5M +1.54M +2.85% May 5, 2021 10-Q 2021-05-05
Q4 2020 55.9M +1.95M +3.61% Feb 11, 2021 10-Q 2021-02-11
Q3 2020 55.8M +1.8M +3.33% Sep 24, 2020 10-K 2020-09-28
Q1 2020 54M +268K +0.5% May 14, 2020 10-Q 2020-05-14
Q4 2019 54M +268K +0.5% Feb 12, 2020 10-Q 2020-02-12
Q3 2019 54M +9.54M +21.5% Sep 25, 2019 10-K 2019-09-30
Q1 2019 53.7M +9.94M +22.7% May 14, 2019 10-Q 2019-05-14
Q4 2018 53.7M +8.82M +19.6% Feb 11, 2019 10-Q 2019-02-14
Q3 2018 44.4M -55.6M -55.6% Sep 25, 2018 10-K 2018-09-28
Q1 2018 43.8M +21.1M +92.7% May 9, 2018 10-Q 2018-05-15
Q4 2017 44.9M +22.2M +97.7% Feb 13, 2018 10-Q 2018-02-14
Q3 2017 100M +77.3M +340% Oct 31, 2017 10-Q 2017-11-03
Q2 2017 22.7M 0 0% Jun 30, 2017 10-K 2017-07-31
Q1 2017 22.7M 0 0% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 22.7M 0 0% Dec 31, 2016 10-Q 2017-02-06
Q3 2016 22.7M 0 0% Sep 30, 2016 10-Q 2016-10-19
Q2 2016 22.7M 0 0% Jun 30, 2016 10-K 2016-09-28
Q1 2016 22.7M 0 0% Mar 31, 2016 10-Q 2016-04-13
Q4 2015 22.7M -9K -0.04% Dec 31, 2015 10-Q 2016-02-04
Q3 2015 22.7M Sep 30, 2015 10-Q 2015-10-14
Q2 2015 22.7M Jun 30, 2015 10-K 2015-09-15
Q1 2015 22.7M Mar 31, 2015 10-Q 2015-05-06
Q4 2014 22.7M Dec 31, 2014 10-Q 2015-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.